Abingworth, an investment group focused on life sciences and healthcare, has made a growth equity investment in Secure EDI. The recapitalisation will provide some liquidity for early investors in the company as well as provide additional equity capital for investment in the business and additional acquisitions. Abingworth is partnering with

Companies backed by private equity investments provide jobs for more than six million Americans, or more than five per cent of all private sector workers, according to analysis by the Private Equity Council. The report, the first to quantify the scope and scale of private equity employment in the US,

Origo Partners’ portfolio company Fans Media has established a joint venture with SK Telecom called SK Fans. SK Telecom is South Korea’s largest telecom service provider. It offers an extensive portfolio of broadband and mobile value-added services and brands, including CyWorld, South Korea’s largest internet community, and CyWorld China, a

QVT Fund, an approximately 7.15 per cent shareholder of Galatasaray Sportif, says it sought to include in Sportif’s 3 May general assembly meeting agenda measures intended to provide for an open and transparent disclosure of the improper loans and other actions of Sportif’s board of directors. These included violations of

Interactive Data, a provider of financial market data, analytics and related solutions, has entered into a definitive agreement to be acquired by investment funds managed by Silver Lake and Warburg Pincus in a transaction with a total value of USD3.4bn.  The agreement was unanimously approved by the Interactive Data board

Private equity firm Apax Partners has signed a definitive agreement to purchase a majority stake in Sophos, an IT security and data protection provider, from the founders of Sophos and TA Associates, valuing the company at USD830m. The founders of Sophos will retain a significant minority shareholding.   Sophos provides

Virtustream, a privately held infrastructure services firm, has closed out a series A round of equity financing with approximately USD40m in total capital. Its latest funding comes from Intel Capital, Noro-Moseley Partners and TDFunds. This completes the series A funding started by lead investors Columbia Capital and Blue Lagoon Capital

Celtic Pharmaceutical, a private equity firm focused on the biotechnology and pharmaceutical industries, has enroled the first patient into its Phase III trial of TDT 067, terbinafine in Transfersomes, for the topical treatment of onychomycosis or fungal nail infection.   The trial is a three-arm, double-blind study to be conducted in